Differentiated Thyroid Cancer
Hemithyroidectomy linked to better quality of life for adults with low-risk thyroid cancer
Hemithyroidectomy is associated with better quality of life after surgery than total thyroidectomy for adults with low-risk differentiated thyroid cancer, though more studies are needed, according to findings from a systematic review.
Dynamic risk stratification accurately predicts risk in pediatric thyroid cancer
The use of dynamic risk stratification can predict long-term outcomes for most children with differentiated thyroid cancer, according to a study published in The Journal of Clinical Endocrinology & Metabolism.
VIDEO: 'Verdict still out' for mono vs. combo therapy for differentiated thyroid cancer
In this video, Maria E. Cabanillas, MD, an oncologic endocrinologist at The University of Texas MD Anderson Cancer Center, discussed important research on immunotherapy combinations presented at American Thyroid Association Annual Meeting.
Overtreatment of low-risk thyroid cancer more common according to Dutch vs. ATA guidelines
Overtreatment of adults with low risk differentiated thyroid cancer is more common using the 2015 Dutch Thyroid Cancer guideline compared with the American Thyroid Association’s guideline, according to study findings.
Most adults with thyroid cancer on levothyroxine do not reach target TSH levels
Most patients with differentiated thyroid cancer on levothyroxine suppression therapy do not have a thyroid-stimulating hormone level within the target range, according to study data published in Clinical Endocrinology.
Anxiety, depression common at follow-up after differentiated thyroid cancer
More than one-third of patients treated for differentiated thyroid cancer reported elevated anxiety and more than 15% reported a high level of depression at an annual follow-up, according to study findings published in Thyroid.
Male sex, low free T4 risk factors for liver dysfunction with radioactive iodine therapy
Among adults who undergo radioactive iodine therapy for differentiated thyroid cancer, risk for hepatic dysfunction is elevated for men and all with low free thyroxine or high triglycerides, according to study data.
Age cutoff of 14 years may be more suitable than 18 years for pediatric thyroid cancer
A cutoff of age 15 years for pediatric differentiated thyroid cancer care may be more appropriate than the American Thyroid Association’s cutoff of 18 years due to risk factors related to survival rates, according to study data.
Thyroidectomy tied to CV complications after cancer diagnosis
Adults with differentiated thyroid cancer who undergo thyroidectomy are at increased risks for atrial fibrillation, cardiovascular disease, increased heart rate and left ventricular mass development, data from a review show.
Decreased BMD observed in post-, not premenopausal women on TSH suppression
Among adults with differentiated thyroid cancer on thyroid-stimulating hormone suppression therapy, postmenopausal women had lower bone mineral density at the lumbar spine whereas premenopausal women had greater BMD vs. healthy controls.